Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Guanylyl cyclase activator
ALX-420-025-M001 1 mg 39.00 USD
ALX-420-025-M005 5 mg 78.00 USD
ALX-420-025-M025 25 mg 357.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: BML-CN223

Nitric oxide (NO) independent, superoxide-sensitive stimulator of soluble guanylyl cyclase (sGC), EC50=18.6μM. Induces concentration-dependent increase in cGMP levels in cultured cells and in rabbit aortic rings. Inhibits platelet adhesion to collagen. Non-specific phosphodiesterase inhibitor. YC-1 inhibits HIF-α activity in tumors resulting in blocked angiogenesis and an inhibition of tumor growth. Inhibits Na+ channel.Binds to [3H]BW202W92.

Product Details

Purity:≥98% (HPLC)
Identity:Identity determined by 1H-NMR.
Appearance:White to pale yellow powder.
Solubility:Soluble in DMSO, methanol or dichloromethane.
Long Term Storage:+4°C
Handling:Protect from light.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Expression of N-WASP is regulated by HiF1α through the hypoxia response element in the N-WASP promoter: A. Salvi & T. Thanabalu; Biochem. Biophys. Rep. 9, 13 (2016), Abstract; Full Text
Selection, Analysis and Improvement of Anti-Angiogenesis Compounds Identified by an Anti-HIF-1α Screening and Validation System: C. Madu, et al.; J. Cancer 7, 1926 (2016), Application(s): Screening for anti-HIF-1α compounds and chemical modification of the lead compound G3, Abstract; Full Text
A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain: D. R. Riddall, et al.; Mol. Pharmacol. 69, 278 (2006), Abstract;
Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition: G. Garthwaite, et al.; Mol. Pharmacol. 61, 97 (2002), Abstract;
Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line: E.M. Becker, et al.; Nitric Oxide 3, 55 (1999), Abstract;
Mechanism of YC-1-induced activation of soluble guanylyl cyclase: A. Friebe & D. Koesling; Mol. Pharmacol. 53, 123 (1998), Abstract; Full Text
Nitric oxide-sensitive guanylyl cyclase inhibits acetylcholine release and excitatory motor transmission in the guinea-pig ileum: K. Hebeiss & H. Kilbinger; Neuroscience 82, 623 (1998), Abstract;
Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide: J.R. Stone & M.A. Marletta; Chem. Biol. 5, 255 (1998), Abstract;
Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat: J.W. Wegener, et al.; Br. J. Pharmacol. 122, 1523 (1997), Abstract;
Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle: J.W. Wegener & H. Nawrath; Eur. J. Pharmacol. 323, 89 (1997), Abstract;
Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators: A. Mülsch, et al.; Br. J. Pharmacol. 120, 681 (1997), Abstract;
Inhibition of platelet adhesion to collagen by cGMP-elevating agents: C.C. Wu, et al.; BBRC 231, 412 (1997), Abstract;
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase: C.C. Wu, et al.; Br. J. Pharmacol. 116, 1973 (1995), Abstract;
YC-1, a novel activator of platelet guanylate cyclase: F.N. Ko, et al.; Blood 84, 4226 (1994), Abstract;

General Literature References

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1: E.J. Yeo, et al.; J. Natl. Cancer Inst. 95, 516 (2003), Abstract;
Inhibition of extracellular Ca(2+) entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils: J.P. Wang, et al.; Biochem. Pharmacol. 62, 679 (2001), Abstract;
Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells: K. Schmidt, et al.; Mol. Pharmacol. 59, 220 (2001), Abstract;
Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism: R. Ferrero & M. Torres; Neuropharmacology 41, 895 (2001), Abstract;
YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components: E. Martin, et al.; Proc. Natl. Acad. Sci. USA 98, 12938 (2001), Abstract;

Related Literature

Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2022 Enzo Life Sciences, Inc.,